Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Common Equity (2020 - 2025)

908 Devices (MASS) has disclosed Common Equity for 6 consecutive years, with $143.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 25.4% to $143.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $143.7 million, a 25.4% increase, with the full-year FY2025 number at $143.7 million, up 25.4% from a year prior.
  • Common Equity was $143.7 million for Q4 2025 at 908 Devices, up from $136.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $214.6 million in Q4 2021 to a low of $114.6 million in Q4 2024.
  • A 5-year average of $161.5 million and a median of $158.2 million in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 301.7% in 2021, then plummeted 30.76% in 2024.
  • 908 Devices' Common Equity stood at $214.6 million in 2021, then dropped by 11.19% to $190.6 million in 2022, then decreased by 13.17% to $165.5 million in 2023, then plummeted by 30.76% to $114.6 million in 2024, then increased by 25.4% to $143.7 million in 2025.
  • Per Business Quant, the three most recent readings for MASS's Common Equity are $143.7 million (Q4 2025), $136.3 million (Q3 2025), and $148.8 million (Q2 2025).